1. |
Morrione A, Neill T, Iozzo RV. Dichotomy of decorin activity on the insulin-like growth factor-Ⅰsystem. FEBS J, 2013, 280(10):2138-2149.
|
2. |
薛立新, 李绪雄, 舒斌, 等.阻断Hedgehog信号通路可抑制胆管癌细胞QBC939的生长.中华肝胆外科杂志, 2013, 19(3):224-229.
|
3. |
Omenetti A, Choi S, Michelotti G, et al. Hedgehog signaling in the liver. J Hepatol, 2011, 54(2):366-373.
|
4. |
Lee CS, Buttitta L, Fan C M. Evidence that the WNT inducible growth arrest specific gene 1 encodes an antagonist of sonic hedgehog signaling in the somite. Proc Natl Acad Sci USA, 2001, 98(20):11347-11352.
|
5. |
子树明, 高军, 杨明, 等.结肠癌中Hedgehog信号转导通路成员的表达及其意义.中国肿瘤生物治疗杂志, 2011, 18(5):539-543.
|
6. |
王伟林, 余翔, 李泉, 等.过表达核心蛋白聚糖基因对胆管癌细胞周期及凋亡的影响.中华实验外科杂志, 2015, 32(1):69-71.
|
7. |
魏洪亮, 丁志强, 俞亚红, 等.肝门部胆管癌中Shh和Ptch的表达与肿瘤侵袭性及根治术后复发的关系.华中科技大学学报:医学版, 2011, 40(2):213-217.
|
8. |
祝珊珊, 李文岗.胆管癌相关信号通路的研究进展.世界华人消化杂志, 2012, 20(30):2913-2919.
|
9. |
Fingas CD, Bronk SF, Werneburg NW, et al. Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocar-cinoma cells. Hepatology, 2011, 54(6):2076-2088.
|
10. |
Jinawath A, Akiyama Y, Sripa B, et al. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells. J Cancer Res Clin Oncol, 2007, 133(4):271-278.
|
11. |
虞玲华, 殷新光, 邬万新, 等.胆囊癌中Hedgehog信号通路效应蛋白的表达及临床意义.中华普通外科杂志, 2013, 28(12):968-969.
|
12. |
郭杰芳, 高军, 李兆申, 等.胰腺癌中GLI1、PTCH1 mRNA的表达及其与临床指标相关性分析.中华胰腺病杂志, 2010, 10(3):196-198.
|
13. |
余翔, 李泉, 毛永欢, 等.核心蛋白聚糖在胆管癌中的表达及其临床意义.中华实验外科杂志, 2014, 31(11):2384-2385.
|
14. |
李晓亮, 肖燎原, 徐志飞, 等.胶质瘤相关癌基因蛋白在肿瘤发生中的作用.现代生物医学进展, 2014, 27(13):5384-5386.
|
15. |
Tushar Patel. Cholangiocarcinoma-controversies and challenges. Nat Rev Gastroenterol Hepatol, 2011, 8(4):189-200.
|
16. |
Zhang BY, Lu Y, Dong Q, et al. Surgical treatment and prognostic analysis of 93 cases of hilar cholangiocarcinoma. Am J Med Sci, 2010, 339(3):221-224.
|
17. |
Briscoe J, Thérond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol, 2013, 14(7):416-429.
|
18. |
董茂盛, 李振, 许小亚, 等.肝门部胆管癌神经浸润的病理学分析及临床意义探讨.中国普外基础与临床杂志, 2015, 22(2):212-215.
|
19. |
刘民锋, 罗剑, 余险峰, 等. PTEN和mTOR信号转导通路在胆管癌发展中作用的研究.中国普通外科杂志, 2006, 15(4):274-276.
|
20. |
胡骁, 胡维昱, 孙传东, 等.肝门部胆管癌根治性切除术后并发症的诊断和治疗.中国现代普通外科进展, 2015, 18(4):328-330.
|
21. |
盛涛, 赵国刚, 徐建, 等. 150例肝外胆管癌的临床病理与预后分析.河北医学, 2015, 21(6):940-942.
|
22. |
Rongyang Dai, Juanjuan Li, Jing Fu, et al. The tyrosine kinase c-Met contributes to the pro-tumorigenic function of the p38 kinase in human bile duct cholangiocarcinoma cells. J Biol Chem, 2012, 287(47):39812-39823.
|
23. |
Boris Blechacz, Mina Komuta, Tania Roskams, et al. Clinical diag-nosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol, 2011, 8(9):512-522.
|
24. |
Nataliya Razumilava, Sergio A. Gradilone, et al. Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma. J Hepatol, 2014, 60(3):599-605.
|
25. |
周良晶, 丁国平, 曹利平, 等.肝门部胆管癌不同分期方法的比较.中华普通外科杂志, 2015, 30(3):177-180.
|
26. |
Kentaroh Yamamoto, Fumio Yamamoto, Atsuhiro Maeda, et al. Tubulopapillary adenoma of the gallbladder accompanied by bile duct tumor thrombus. World J Gastroenterol, 2014, 20(26):8736-8739.
|